V · Healthcare

XORTX Therapeutics Inc (XRTX)

Biotechnology

XORTX Therapeutics Inc (XRTX) is listed on V in the Healthcare sector. Industry: Biotechnology. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for XRTX

P/E ratio

18.00

XORTX Therapeutics Inc (XRTX) — FAQ

What is XRTX's P/E ratio?

The price-to-earnings (P/E) ratio for XORTX Therapeutics Inc (XRTX) is 18.00 (data as of 2026-03-23).

Does XORTX Therapeutics Inc pay a dividend?

Dividend yield is not available in the current snapshot for XORTX Therapeutics Inc (XRTX). Check the MyAverix Finance app for the latest dividend data.

What sector is XORTX Therapeutics Inc in?

XORTX Therapeutics Inc (XRTX) is classified in the Healthcare sector (Biotechnology industry).

What exchange is XRTX listed on?

XRTX is listed on V.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)